<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03464643</url>
  </required_header>
  <id_info>
    <org_study_id>KYXM-20180307</org_study_id>
    <nct_id>NCT03464643</nct_id>
  </id_info>
  <brief_title>A Prospective Study Comparing the Outcomes of Single Versus Group Culture in Preimplantation Genetic Testing Cycles</brief_title>
  <official_title>A Prospective Study Comparing the Outcomes of Single Embryo Culture Versus Group Culture in Preimplantation Genetic Testing Cycles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to analyze whether there is difference in the effect of single
      embryo culture and group culture in preimplantation genetic screening (PGS) cycle, and
      provide reference for the feasibility of the clinical application of medium-based noninvasive
      PGD. This prospective study prepares for more than 1,000 normal fertilized zygotes in each
      group over one year period. For the recruited patients, all normal fertilized zygotes were
      randomly allocated into two groups: cultured individually in 25 ul media or 2-3 embryos
      cultured together in 50 ul media. The blastocyst formation rates, aneuploid rates, clinical
      pregnancy rates, implantation rates and miscarriage rates will be compared between the two
      groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2017</start_date>
  <completion_date type="Anticipated">September 23, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 23, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>high quality blastocyst formation rate</measure>
    <time_frame>6 days after fertilization</time_frame>
    <description>number of blastocysts with high quality divided by number of zygotes with normal fertilization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>embryo euploid rate</measure>
    <time_frame>about one month after blastocyst biopsy</time_frame>
    <description>number of euploid blastocysts divided by all blastocysts detected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>embryo implantation rate</measure>
    <time_frame>about three to six months after blastocyst biopsy</time_frame>
    <description>number of gestational sacs divided by number of embryo transferred</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">236</enrollment>
  <condition>Embryo Culture</condition>
  <arm_group>
    <arm_group_label>Single embryo culture</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Embryo is cultured individually in 25 ul media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group embryo culture</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>2-3 Embryos are group cultured in 50 ul media</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>embryo culture</intervention_name>
    <description>Single embryo culture means only one embryo is cultured in one drop, and the group culture refers to culture of 2-5 embryos in one drop. The main advantage of group culture may be secreting some paracrine cytokines by embryos and benefit each other; and the possible disadvantage of group culture is that embryo secreting of some harmful substances which accumulated to a certain extent will damage the developmental potential of embryos. The advantages and disadvantages of single embryo culture are contrary to group culture.</description>
    <arm_group_label>Group embryo culture</arm_group_label>
    <arm_group_label>Single embryo culture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients treated by preimplantation genetic diagnostic / screening cycles

        Exclusion Criteria:

          -  number of normal fertilization zygotes is less than 6
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaojuan Wang, Doc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Reproductive and Genetic Hospital of Citic-xiangya</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shuoping Zhang, Doc</last_name>
    <phone>+86-731-88395640</phone>
    <email>baibaipang@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lu Tan, Mrs</last_name>
    <phone>+86-731-82355100</phone>
    <email>10931212@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Reproductive and Genetic Hospital of Citic-xiangya</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaojuan Wang, Doc</last_name>
      <phone>+86-731-82355100</phone>
      <email>646829625@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>March 7, 2018</study_first_submitted>
  <study_first_submitted_qc>March 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2018</study_first_posted>
  <last_update_submitted>December 6, 2018</last_update_submitted>
  <last_update_submitted_qc>December 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

